Oktatási központ
Munkahely
Témavezető
Védett
Igen
Évfolyam:
2021/22
Kutatási terület:
Nőgyógyászat és urológia
Ország:
Magyarország
PhD szakterület:
urológia
TOPIC
Urology – Oncology of urothelial cancers and biomarkers for immunotherapy.
VISION
Optimize therapy for urothelial cancers.
MISSION
Leverage biomarkers in patients treated with immune checkpoint inhibitors.
PROJECT TITLE 1
Pre–treatment soluble PD–L1 as a predictor of overall survival with immune checkpoint inhibitor therapy: a systematic review and meta–analysis.
PROJECT TITLE 2
High pre–treatment sPD–L1 is associated with muscle invasion and shorter survival in UTUC: a post–hoc analysis of prospectively collected serum samples.
PROJECT TITLE 3
Prognostic significance of NLR, PLR, C–reactive protein, and LDH in urothelial cancer treated with immune checkpoint inhibitors: a systematic review and meta–analysis.
Publications
- High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma - IF: 4.700, Quality: Q1, Journal: Biomedicines
- Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis - IF: 5.800, Quality: Q1, Journal: Cancer Immunol Immunother
- Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis - IF: 5.700, Quality: Q1, Journal: Front Immunol